Literature DB >> 25028730

Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?

Bernard L Marini1, Anthony J Perissinotti2, Angela M Huang3, David G Frame2, Daniel R Kaul4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25028730      PMCID： PMC4136026          DOI： 10.1128/AAC.03044-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Revisiting the source of candidemia: skin or gut?

Authors:  M Nucci; E Anaissie
Journal:  Clin Infect Dis       Date:  2001-11-08       Impact factor: 9.079

Review 2.  Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Authors:  Nicole M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

3.  Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.

Authors:  Gloria N Mattiuzzi; Gladys Alvarado; Francis J Giles; Luis Ostrosky-Zeichner; Jorge Cortes; Susan O'brien; Srdan Verstovsek; Stefan Faderl; Xian Zhou; Issam I Raad; B Nebiyou Bekele; G J Leitz; Ivonne Lopez-Roman; Elihu H Estey
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

5.  Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults.

Authors:  E J Bow; R Loewen; M S Cheang; T B Shore; M Rubinger; B Schacter
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

Review 6.  Invasive candidiasis in the intensive care unit.

Authors:  Luis Ostrosky-Zeichner; Peter G Pappas
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

7.  Fungal infection: a common, unrecognised complication of acute liver failure.

Authors:  N Rolando; F Harvey; J Brahm; J Philpott-Howard; G Alexander; M Casewell; E Fagan; R Williams
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

8.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

Review 9.  Infections in Patients With End-stage Liver Disease.

Authors:  Rekha Cheruvattath; Vijayan Balan
Journal:  J Clin Gastroenterol       Date:  2007-04       Impact factor: 3.062

10.  Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.

Authors:  Marisa Z R Gomes; Victor E Mulanovich; Y Jiang; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191
View more
  2 in total

1.  Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?".

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Antimicrob Agents Chemother       Date:  2014-08       Impact factor: 5.191

2.  Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy.

Authors:  Heena P Patel; Anthony J Perissinotti; Twisha S Patel; Dale L Bixby; Vincent D Marshall; Bernard L Marini
Journal:  Open Forum Infect Dis       Date:  2019-04-12       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.